Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
KLRA
KLRA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KLRA News
Kardigan's Shares Rise 1.6% in Successful Nasdaq Debut
2d ago
Yahoo Finance
Three Innovative Biotechs with Promising Prospects
4d ago
NASDAQ.COM
Analysis of Three Promising Biotech Companies
4d ago
Fool
Moderna's Strategic Return and Future Outlook
5d ago
Yahoo Finance
Parabilis Pharmaceuticals IPO Raises $670 Million, Stock Surges 58%
Jun 12 2026
Fool
Parabilis IPO Sets Record, Promising Biotech Prospects Ahead
Jun 12 2026
NASDAQ.COM
Parabilis Achieves Record Biotech IPO with $670 Million Raise
Jun 12 2026
Yahoo Finance
Clinical Results for Ribupatide Unveiled at ADA
Jun 05 2026
Newsfilter
Kailera Therapeutics Reports Q1 Net Loss of $78.9 Million
May 26 2026
seekingalpha
Kailera Therapeutics Makes Successful IPO Amid Biotech Surge
May 16 2026
Fool
Hengrui Pharma and Kailera Showcase New Drug at ADA
May 13 2026
Newsfilter
Latest Wall Street Ratings Overview
May 12 2026
CNBC
Odyssey Therapeutics Raises $279 Million in Upsized IPO
May 08 2026
Newsfilter
April IPO Market Rebounds with $7.3 Billion Raised
May 01 2026
renaissancecapital
RTW Investments Acquires Shares in Kailera Therapeutics
Apr 27 2026
Fool
Hengrui Pharma Reports Steady Growth in Q1 2026
Apr 22 2026
Newsfilter
Show More News
